CHI3L1 and central nervous system cancer: In this study, we aimed to explore the value of CHI3L1 in predicting tumor progress and uncover the potential mechanisms by which CHI3L1 induces poor outcomes in patients with gliomas, providing guidance for the development of targeted treatments in the future.